Skip to main
AHR
AHR logo

AHR Stock Forecast & Price Target

AHR Analyst Ratings

Based on 10 analyst ratings
Buy
Strong Buy 30%
Buy 70%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

American Healthcare REIT Inc. is poised for growth, highlighted by a 4.1% year-over-year increase in rental rates, positioning the company favorably within the healthcare real estate sector. The company stands to benefit from an increase in revenue through Medicare Advantage plans, which are linked to enhanced operational outcomes and align with its focus on quality healthcare facilities. Furthermore, the management's positive outlook on outpatient medical buildings suggests an anticipated revival in this segment, supported by favorable supply and demand dynamics within the healthcare real estate market.

Bears say

American Healthcare REIT Inc. displays a concerning financial outlook, with its leverage reduced to 31.1% on a net debt to gross asset value basis, down from 42.2% the previous year, indicating a focus on managing debt levels. Despite a favorable net debt to annualized EBITDA ratio of 3.7x, potential tenant performance issues stemming from economic or regulatory shifts could hinder the company’s ability to meet earnings expectations and negatively affect its stock performance. Additionally, limited inventory growth and a significant decline in units under construction raise development and tenant risk, exacerbating uncertainty around achieving organic net operating income growth.

AHR has been analyzed by 10 analysts, with a consensus rating of Buy. 30% of analysts recommend a Strong Buy, 70% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of American Healthcare REIT Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About American Healthcare REIT Inc (AHR) Forecast

Analysts have given AHR a Buy based on their latest research and market trends.

According to 10 analysts, AHR has a Buy consensus rating as of Nov 4, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $44, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $44, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

American Healthcare REIT Inc (AHR)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.